These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 34873640)

  • 1. Development of Lipidoid Nanoparticles for siRNA Delivery to Neural Cells.
    Khare P; Dave KM; Kamte YS; Manoharan MA; O'Donnell LA; Manickam DS
    AAPS J; 2021 Dec; 24(1):8. PubMed ID: 34873640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid Nanoparticle Formulations for Enhanced Co-delivery of siRNA and mRNA.
    Ball RL; Hajj KA; Vizelman J; Bajaj P; Whitehead KA
    Nano Lett; 2018 Jun; 18(6):3814-3822. PubMed ID: 29694050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitation of physiological and biochemical barriers to siRNA liver delivery via lipid nanoparticle platform.
    Xu Y; Ou M; Keough E; Roberts J; Koeplinger K; Lyman M; Fauty S; Carlini E; Stern M; Zhang R; Yeh S; Mahan E; Wang Y; Slaughter D; Gindy M; Raab C; Thompson C; Hochman J
    Mol Pharm; 2014 May; 11(5):1424-34. PubMed ID: 24588618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways.
    Tam A; Kulkarni J; An K; Li L; Dorscheid DR; Singhera GK; Bernatchez P; Reid G; Chan K; Witzigmann D; Cullis PR; Sin DD; Lim CJ
    Eur J Pharm Sci; 2022 Sep; 176():106234. PubMed ID: 35688311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced hepatic delivery of siRNA and microRNA using oleic acid based lipid nanoparticle formulations.
    Wang X; Yu B; Ren W; Mo X; Zhou C; He H; Jia H; Wang L; Jacob ST; Lee RJ; Ghoshal K; Lee LJ
    J Control Release; 2013 Dec; 172(3):690-8. PubMed ID: 24121065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid nanoparticle-mediated drug delivery to the brain.
    Khare P; Edgecomb SX; Hamadani CM; Tanner EEL; S Manickam D
    Adv Drug Deliv Rev; 2023 Jun; 197():114861. PubMed ID: 37150326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced Delivery of siRNA to Retinal Ganglion Cells by Intravitreal Lipid Nanoparticles of Positive Charge.
    Huang X; Chau Y
    Mol Pharm; 2021 Jan; 18(1):377-385. PubMed ID: 33295773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipidoid nanoparticles increase ATP uptake into hypoxic brain endothelial cells.
    Khare P; Conway JF; S Manickam D
    Eur J Pharm Biopharm; 2022 Nov; 180():238-250. PubMed ID: 36265829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stabilization of Ostwald ripening in low molecular weight amino lipid nanoparticles for systemic delivery of siRNA therapeutics.
    Gindy ME; Feuston B; Glass A; Arrington L; Haas RM; Schariter J; Stirdivant SM
    Mol Pharm; 2014 Nov; 11(11):4143-53. PubMed ID: 25317715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemistry of Lipid Nanoparticles for RNA Delivery.
    Eygeris Y; Gupta M; Kim J; Sahay G
    Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substituting racemic ionizable lipids with stereopure ionizable lipids can increase mRNA delivery.
    Da Silva Sanchez AJ; Zhao K; Huayamares SG; Hatit MZC; Lokugamage MP; Loughrey D; Dobrowolski C; Wang S; Kim H; Paunovska K; Kuzminich Y; Dahlman JE
    J Control Release; 2023 Jan; 353():270-277. PubMed ID: 36423872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid nanoparticles for hepatic delivery of small interfering RNA.
    Yu B; Hsu SH; Zhou C; Wang X; Terp MC; Wu Y; Teng L; Mao Y; Wang F; Xue W; Jacob ST; Ghoshal K; Lee RJ; Lee LJ
    Biomaterials; 2012 Sep; 33(25):5924-34. PubMed ID: 22652024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a Microfluidic-Based Post-Treatment Process for Size-Controlled Lipid Nanoparticles and Application to siRNA Delivery.
    Kimura N; Maeki M; Sato Y; Ishida A; Tani H; Harashima H; Tokeshi M
    ACS Appl Mater Interfaces; 2020 Jul; 12(30):34011-34020. PubMed ID: 32667806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polydispersity characterization of lipid nanoparticles for siRNA delivery using multiple detection size-exclusion chromatography.
    Zhang J; Haas RM; Leone AM
    Anal Chem; 2012 Jul; 84(14):6088-96. PubMed ID: 22816783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Combinatorial Library of Lipid Nanoparticles for RNA Delivery to Leukocytes.
    Ramishetti S; Hazan-Halevy I; Palakuri R; Chatterjee S; Naidu Gonna S; Dammes N; Freilich I; Kolik Shmuel L; Danino D; Peer D
    Adv Mater; 2020 Mar; 32(12):e1906128. PubMed ID: 31999380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing the siRNA knockdown efficiency of lipid nanoparticles by morphological transformation with the use of dihydrosphingomyelin as a helper lipid.
    Hashimoto M; Yonezawa S; Furan S; Nitta C; Maeda N; Tomita K; Yokouchi A; Koide H; Asai T
    Biomater Sci; 2023 May; 11(9):3269-3277. PubMed ID: 36939181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human serum albumin-coated lipid nanoparticles for delivery of siRNA to breast cancer.
    Piao L; Li H; Teng L; Yung BC; Sugimoto Y; Brueggemeier RW; Lee RJ
    Nanomedicine; 2013 Jan; 9(1):122-9. PubMed ID: 22542825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanometer-scale siRNA carriers incorporating peptidomimetic oligomers: physical characterization and biological activity.
    Konca YU; Kirshenbaum K; Zuckermann RN
    Int J Nanomedicine; 2014; 9():2271-85. PubMed ID: 24872690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralization of negative charges of siRNA results in improved safety and efficient gene silencing activity of lipid nanoparticles loaded with high levels of siRNA.
    Sato Y; Matsui H; Sato R; Harashima H
    J Control Release; 2018 Aug; 284():179-187. PubMed ID: 29936118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of DLin-MC3-DMA and ALC-0315 for siRNA Delivery to Hepatocytes and Hepatic Stellate Cells.
    Ferraresso F; Strilchuk AW; Juang LJ; Poole LG; Luyendyk JP; Kastrup CJ
    Mol Pharm; 2022 Jul; 19(7):2175-2182. PubMed ID: 35642083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.